Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature

References

• Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 2005; 64:479 - 89; PMID: 15977639
   PubMed Web of Science ®Google Scholar
• Filippini G, Falcone C, Boiardi A, Broggi G, Bruzzone MG, Caldiroli D, Farina R, Farinotti M, Fariselli L, Finocchiaro G, et al, Brain Cancer Register of the Fondazione IRCCS (Istituto Ricovero e Cura a Carattere Scientifico) Istituto Neurologico Carlo Besta. Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro Oncol 2008; 10:79 - 87; http://dx.doi.org/10.1215/15228517-2007-038; PMID: 17993634
   PubMed Web of Science ®Google Scholar
• Lathia JD, Gallagher J, Myers JT, Li M, Vasanji A, McLendon RE, Hjelmeland AB, Huang AY, Rich JN. Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells. PLoS One 2011; 6:e24807; http://dx.doi.org/10.1371/journal.pone.0024807; PMID: 21961046
   PubMedGoogle Scholar
• Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444:756 - 60; http://dx.doi.org/10.1038/nature05236; PMID: 17051156
   PubMed Web of Science ®Google Scholar
• Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, Shi Q, McLendon RE, Bigner DD, Rich JN. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 2006; 66:7843 - 8; http://dx.doi.org/10.1158/0008-5472.CAN-06-1010; PMID: 16912155
   PubMed Web of Science ®Google Scholar
• Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL, Yu JS. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006; 5:67; http://dx.doi.org/10.1186/1476-4598-5-67; PMID: 17140455
   PubMed Web of Science ®Google Scholar
• Huang Q, Zhang QB, Dong J, Wu YY, Shen YT, Zhao YD, Zhu YD, Diao Y, Wang AD, Lan Q. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro. BMC Cancer 2008; 8:304; http://dx.doi.org/10.1186/1471-2407-8-304; PMID: 18940013
   PubMed Web of Science ®Google Scholar
• Mariani CL, Kouri JG, Streit WJ. Rejection of RG-2 gliomas is mediated by microglia and T lymphocytes. J Neurooncol 2006; 79:243 - 53; http://dx.doi.org/10.1007/s11060-006-9137-x; PMID: 16612573
   PubMed Web of Science ®Google Scholar
• Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002; 39:193 - 206; http://dx.doi.org/10.1002/glia.10094; PMID: 12203386
   PubMed Web of Science ®Google Scholar
• Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63:5821 - 8; PMID: 14522905
   PubMed Web of Science ®Google Scholar
• Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature 2004; 432:396 - 401; http://dx.doi.org/10.1038/nature03128; PMID: 15549107
   PubMed Web of Science ®Google Scholar
• Chiba S. Notch signaling in stem cell systems. Stem Cells 2006; 24:2437 - 47; http://dx.doi.org/10.1634/stemcells.2005-0661; PMID: 16888285
   PubMed Web of Science ®Google Scholar
• Beatus P, Lendahl U. Notch and neurogenesis. J Neurosci Res 1998; 54:125 - 36; http://dx.doi.org/10.1002/(SICI)1097-4547(19981015)54:2<125::AID-JNR1>3.0.CO;2-G; PMID: 9788272
   PubMed Web of Science ®Google Scholar
• Margareto J, Leis O, Larrarte E, Idoate MA, Carrasco A, Lafuente JV. Gene expression profiling of human gliomas reveals differences between GBM and LGA related to energy metabolism and notch signaling pathways. J Mol Neurosci 2007; 32:53 - 63; http://dx.doi.org/10.1007/s12031-007-0008-5; PMID: 17873288
   PubMed Web of Science ®Google Scholar
• Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006; 9:391 - 403; http://dx.doi.org/10.1016/j.ccr.2006.03.030; PMID: 16697959
   PubMed Web of Science ®Google Scholar
• Purow BW, Haque RM, Noel MW, Su Q, Burdick MJ, Lee J, Sundaresan T, Pastorino S, Park JK, Mikolaenko I, et al. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res 2005; 65:2353 - 63; http://dx.doi.org/10.1158/0008-5472.CAN-04-1890; PMID: 15781650
   PubMed Web of Science ®Google Scholar
• Hu YY, Zheng MH, Cheng G, Li L, Liang L, Gao F, Wei YN, Fu LA, Han H. Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells. BMC Cancer 2011; 11:82; http://dx.doi.org/10.1186/1471-2407-11-82; PMID: 21342503
   PubMed Web of Science ®Google Scholar
• Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, et al. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 2010; 28:5 - 16; PMID: 19904829
   PubMed Web of Science ®Google Scholar
• Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, et al, Cancer Genome Atlas Research Network. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010; 17:98 - 110; http://dx.doi.org/10.1016/j.ccr.2009.12.020; PMID: 20129251
   PubMed Web of Science ®Google Scholar
• Bezwoda WR, Derman D, De Moor NG, Lange M, Levin J. Treatment of metastatic breast cancer in estrogen receptor positive patients. A randomized trial comparing tamoxifen alone versus tamoxifen plus CMF. Cancer 1982; 50:2747 - 50; http://dx.doi.org/10.1002/1097-0142(19821215)50:12<2747::AID-CNCR2820501209>3.0.CO;2-Y; PMID: 6754067
   PubMed Web of Science ®Google Scholar
• Marty M, Cognetti F, Maraninchi D, Snyder R, Mauriac L, Tubiana-Hulin M, Chan S, Grimes D, Antón A, Lluch A, et al. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group. J Clin Oncol 2005; 23:4265 - 74; http://dx.doi.org/10.1200/JCO.2005.04.173; PMID: 15911866
   PubMed Web of Science ®Google Scholar
• Andersen J, Poulsen HS. Immunohistochemical estrogen receptor determination in paraffin-embedded tissue. Prediction of response to hormonal treatment in advanced breast cancer. Cancer 1989; 64:1901 - 8; http://dx.doi.org/10.1002/1097-0142(19891101)64:9<1901::AID-CNCR2820640924>3.0.CO;2-W; PMID: 2790701
   PubMed Web of Science ®Google Scholar
• Kristoffersen K, Villingshøj M, Poulsen HS, Stockhausen MT. Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures. Cancer Biol Ther 2013; 14:625 - 37; http://dx.doi.org/10.4161/cbt.24595; PMID: 23792644
   PubMed Web of Science ®Google Scholar
• Stockhausen MT, Broholm H, Villingshøj M, Kirchhoff M, Gerdes T, Kristoffersen K, Kosteljanetz M, Spang-Thomsen M, Poulsen HS. Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme. Exp Cell Res 2011; 317:1513 - 26; http://dx.doi.org/10.1016/j.yexcr.2011.04.001; PMID: 21514294
   PubMed Web of Science ®Google Scholar
• Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006; 9:157 - 73; http://dx.doi.org/10.1016/j.ccr.2006.02.019; PMID: 16530701
   PubMed Web of Science ®Google Scholar
• Brennan C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, Pedraza A, Holland E. Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS One 2009; 4:e7752; http://dx.doi.org/10.1371/journal.pone.0007752; PMID: 19915670
   PubMed Web of Science ®Google Scholar
• Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005; 352:997 - 1003; http://dx.doi.org/10.1056/NEJMoa043331; PMID: 15758010
   PubMed Web of Science ®Google Scholar
• Henrique D, Hirsinger E, Adam J, Le Roux I, Pourquié O, Ish-Horowicz D, Lewis J. Maintenance of neuroepithelial progenitor cells by Delta-Notch signalling in the embryonic chick retina. Curr Biol 1997; 7:661 - 70; http://dx.doi.org/10.1016/S0960-9822(06)00293-4; PMID: 9285721
   PubMed Web of Science ®Google Scholar
• Fischer A, Gessler M. Delta-Notch--and then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factors. Nucleic Acids Res 2007; 35:4583 - 96; http://dx.doi.org/10.1093/nar/gkm477; PMID: 17586813
   PubMed Web of Science ®Google Scholar
• Raafat A, Lawson S, Bargo S, Klauzinska M, Strizzi L, Goldhar AS, Buono K, Salomon D, Vonderhaar BK, Callahan R. Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis. Oncogene 2009; 28:219 - 30; http://dx.doi.org/10.1038/onc.2008.379; PMID: 18836481
   PubMed Web of Science ®Google Scholar
• Harrison H, Farnie G, Howell SJ, Rock RE, Stylianou S, Brennan KR, Bundred NJ, Clarke RB. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res 2010; 70:709 - 18; http://dx.doi.org/10.1158/0008-5472.CAN-09-1681; PMID: 20068161
   PubMed Web of Science ®Google Scholar
• Speiser J, Foreman K, Drinka E, Godellas C, Perez C, Salhadar A, Erşahin Ç, Rajan P. Notch-1 and Notch-4 biomarker expression in triple-negative breast cancer. Int J Surg Pathol 2012; 20:139 - 45; http://dx.doi.org/10.1177/1066896911427035; PMID: 22084425
   PubMed Web of Science ®Google Scholar
• Gentle ME, Rose A, Bugeon L, Dallman MJ. Noncanonical Notch signaling modulates cytokine responses of dendritic cells to inflammatory stimuli. J Immunol 2012; 189:1274 - 84; http://dx.doi.org/10.4049/jimmunol.1103102; PMID: 22753939
   PubMed Web of Science ®Google Scholar
• Evin G, Cappai R, Li QX, Culvenor JG, Small DH, Beyreuther K, Masters CL. Candidate gamma-secretases in the generation of the carboxyl terminus of the Alzheimer’s disease beta A4 amyloid: possible involvement of cathepsin D. Biochemistry 1995; 34:14185 - 92; http://dx.doi.org/10.1021/bi00043a024; PMID: 7578016
   PubMed Web of Science ®Google Scholar
• Blumenthal RD, Hansen HJ, Goldenberg DM. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen). Cancer Res 2005; 65:8809 - 17; http://dx.doi.org/10.1158/0008-5472.CAN-05-0420; PMID: 16204051
   PubMed Web of Science ®Google Scholar
• Patriarca C, Macchi RM, Marschner AK, Mellstedt H. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review. Cancer Treat Rev 2012; 38:68 - 75; http://dx.doi.org/10.1016/j.ctrv.2011.04.002; PMID: 21576002
   PubMed Web of Science ®Google Scholar
• Bajaj J, Maliekal TT, Vivien E, Pattabiraman C, Srivastava S, Krishnamurthy H, Giri V, Subramanyam D, Krishna S. Notch signaling in CD66+ cells drives the progression of human cervical cancers. Cancer Res 2011; 71:4888 - 97; http://dx.doi.org/10.1158/0008-5472.CAN-11-0543; PMID: 21646470
   PubMed Web of Science ®Google Scholar
• Palagani V, El Khatib M, Kossatz U, Bozko P, Müller MR, Manns MP, Krech T, Malek NP, Plentz RR. Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX. PLoS One 2012; 7:e46514; http://dx.doi.org/10.1371/journal.pone.0046514; PMID: 23094026
   PubMed Web of Science ®Google Scholar
• Shawber CJ, Das I, Francisco E, Kitajewski J. Notch signaling in primary endothelial cells. Ann N Y Acad Sci 2003; 995:162 - 70; http://dx.doi.org/10.1111/j.1749-6632.2003.tb03219.x; PMID: 12814948
   PubMed Web of Science ®Google Scholar
• Lawson ND, Scheer N, Pham VN, Kim CH, Chitnis AB, Campos-Ortega JA, Weinstein BM. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 2001; 128:3675 - 83; PMID: 11585794
   PubMed Web of Science ®Google Scholar
• Isackson PJ, Ochs-Balcom HM, Ma C, Harley JB, Peltier W, Tarnopolsky M, Sripathi N, Wortmann RL, Simmons Z, Wilson JD, et al. Association of common variants in the human eyes shut ortholog (EYS) with statin-induced myopathy: evidence for additional functions of EYS. Muscle Nerve 2011; 44:531 - 8; http://dx.doi.org/10.1002/mus.22115; PMID: 21826682
   PubMed Web of Science ®Google Scholar
• Xu P, Yu S, Jiang R, Kang C, Wang G, Jiang H, Pu P. Differential expression of Notch family members in astrocytomas and medulloblastomas. Pathol Oncol Res 2009; 15:703 - 10; http://dx.doi.org/10.1007/s12253-009-9173-x; PMID: 19424825
   PubMed Web of Science ®Google Scholar
• Zhang X, Chen T, Zhang J, Mao Q, Li S, Xiong W, Qiu Y, Xie Q, Ge J. Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation. Cancer Sci 2012; 103:181 - 90; http://dx.doi.org/10.1111/j.1349-7006.2011.02154.x; PMID: 22093097
   PubMed Web of Science ®Google Scholar
• Jandial R, U H, Levy ML, Snyder EY. Brain tumor stem cells and the tumor microenvironmen. Neurosurg Focus 2008; 24:E27; http://dx.doi.org/10.3171/FOC/2008/24/3-4/E26; PMID: 18341404
   PubMedGoogle Scholar
• Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992; 255:1707 - 10; http://dx.doi.org/10.1126/science.1553558; PMID: 1553558
   PubMed Web of Science ®Google Scholar
• Gritti A, Parati EA, Cova L, Frolichsthal P, Galli R, Wanke E, Faravelli L, Morassutti DJ, Roisen F, Nickel DD, et al. Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. J Neurosci 1996; 16:1091 - 100; PMID: 8558238
   PubMed Web of Science ®Google Scholar
• Gritti A, Frölichsthal-Schoeller P, Galli R, Parati EA, Cova L, Pagano SF, Bjornson CR, Vescovi AL. Epidermal and fibroblast growth factors behave as mitogenic regulators for a single multipotent stem cell-like population from the subventricular region of the adult mouse forebrain. J Neurosci 1999; 19:3287 - 97; PMID: 10212288
   PubMed Web of Science ®Google Scholar
• Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F, Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004; 64:7011 - 21; http://dx.doi.org/10.1158/0008-5472.CAN-04-1364; PMID: 15466194
   PubMed Web of Science ®Google Scholar
• He H, Niu CS, Li MW. Correlation between glioblastoma stem-like cells and tumor vascularization. Oncol Rep 2012; 27:45 - 50; PMID: 21971709
   PubMed Web of Science ®Google Scholar
• Li JL, Sainson RC, Shi W, Leek R, Harrington LS, Preusser M, Biswas S, Turley H, Heikamp E, Hainfellner JA, et al. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Cancer Res 2007; 67:11244 - 53; http://dx.doi.org/10.1158/0008-5472.CAN-07-0969; PMID: 18056450
   PubMed Web of Science ®Google Scholar
• Noguera-Troise I, Daly C, Papadopoulos NJ, Coetzee S, Boland P, Gale NW, Lin HC, Yancopoulos GD, Thurston G. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 2006; 444:1032 - 7; http://dx.doi.org/10.1038/nature05355; PMID: 17183313
   PubMed Web of Science ®Google Scholar
• Thurston G, Noguera-Troise I, Yancopoulos GD. The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth. Nat Rev Cancer 2007; 7:327 - 31; http://dx.doi.org/10.1038/nrc2130; PMID: 17457300
   PubMed Web of Science ®Google Scholar
• Sainson RC, Harris AL. Anti-Dll4 therapy: can we block tumour growth by increasing angiogenesis?. Trends Mol Med 2007; 13:389 - 95; http://dx.doi.org/10.1016/j.molmed.2007.07.002; PMID: 17822956
   PubMed Web of Science ®Google Scholar
• Li JL, Sainson RC, Oon CE, Turley H, Leek R, Sheldon H, Bridges E, Shi W, Snell C, Bowden ET, et al. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo. Cancer Res 2011; 71:6073 - 83; http://dx.doi.org/10.1158/0008-5472.CAN-11-1704; PMID: 21803743
   PubMed Web of Science ®Google Scholar
• Borghese L, Dolezalova D, Opitz T, Haupt S, Leinhaas A, Steinfarz B, Koch P, Edenhofer F, Hampl A, Brüstle O. Inhibition of notch signaling in human embryonic stem cell-derived neural stem cells delays G1/S phase transition and accelerates neuronal differentiation in vitro and in vivo. Stem Cells 2010; 28:955 - 64; http://dx.doi.org/10.1002/stem.408; PMID: 20235098
   PubMed Web of Science ®Google Scholar
• Hitoshi S, Alexson T, Tropepe V, Donoviel D, Elia AJ, Nye JS, Conlon RA, Mak TW, Bernstein A, van der Kooy D. Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells. Genes Dev 2002; 16:846 - 58; http://dx.doi.org/10.1101/gad.975202; PMID: 11937492
   PubMed Web of Science ®Google Scholar
• Imayoshi I, Sakamoto M, Yamaguchi M, Mori K, Kageyama R. Essential roles of Notch signaling in maintenance of neural stem cells in developing and adult brains. J Neurosci 2010; 30:3489 - 98; http://dx.doi.org/10.1523/JNEUROSCI.4987-09.2010; PMID: 20203209
   PubMed Web of Science ®Google Scholar
• Zhen Y, Zhao S, Li Q, Li Y, Kawamoto K. Arsenic trioxide-mediated Notch pathway inhibition depletes the cancer stem-like cell population in gliomas. Cancer Lett 2010; 292:64 - 72; http://dx.doi.org/10.1016/j.canlet.2009.11.005; PMID: 19962820
   PubMed Web of Science ®Google Scholar
• Monticone M, Biollo E, Fabiano A, Fabbi M, Daga A, Romeo F, Maffei M, Melotti A, Giaretti W, Corte G, et al. z-Leucinyl-leucinyl-norleucinal induces apoptosis of human glioblastoma tumor-initiating cells by proteasome inhibition and mitotic arrest response. Mol Cancer Res 2009; 7:1822 - 34; http://dx.doi.org/10.1158/1541-7786.MCR-09-0225; PMID: 19861404
   PubMed Web of Science ®Google Scholar
• Shih AH, Holland EC. Notch signaling enhances nestin expression in gliomas. Neoplasia 2006; 8:1072 - 82; http://dx.doi.org/10.1593/neo.06526; PMID: 17217625
   PubMed Web of Science ®Google Scholar
• Dirks PB. Brain tumor stem cells: bringing order to the chaos of brain cancer. J Clin Oncol 2008; 26:2916 - 24; http://dx.doi.org/10.1200/JCO.2008.17.6792; PMID: 18539973
   PubMed Web of Science ®Google Scholar
• Bleau AM, Howard BM, Taylor LA, Gursel D, Greenfield JP, Lim Tung HY, Holland EC, Boockvar JA. New strategy for the analysis of phenotypic marker antigens in brain tumor-derived neurospheres in mice and humans. Neurosurg Focus 2008; 24:E28; http://dx.doi.org/10.3171/FOC/2008/24/3-4/E27; PMID: 18341405
   PubMedGoogle Scholar
• Yang ZJ, Wechsler-Reya RJ. Hit ’em where they live: targeting the cancer stem cell niche. Cancer Cell 2007; 11:3 - 5; http://dx.doi.org/10.1016/j.ccr.2006.12.007; PMID: 17222787
   PubMed Web of Science ®Google Scholar
• Fan X, Mikolaenko I, Elhassan I, Ni X, Wang Y, Ball D, Brat DJ, Perry A, Eberhart CG. Notch1 and notch2 have opposite effects on embryonal brain tumor growth. Cancer Res 2004; 64:7787 - 93; http://dx.doi.org/10.1158/0008-5472.CAN-04-1446; PMID: 15520184
   PubMed Web of Science ®Google Scholar
• Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR, Rich JN, Sullenger BA. Notch promotes radioresistance of glioma stem cells. Stem Cells 2010; 28:17 - 28; PMID: 19921751
   PubMed Web of Science ®Google Scholar
• Binderup T, El-Ali HH, Ambrosini V, Skovgaard D, Jensen MM, Hesse B, Jorgensen JT, Kjaer A. Molecular Imaging with Small Animal PET/CT. Curr Med Imaging Rev 2011; 7:234 - 47; http://dx.doi.org/10.2174/157340511796411221
   Web of Science ®Google Scholar